FDA-Drafted Folic Acid Health Claim Disclaimers Ordered By Federal Judge

FDA must draft "one or more appropriately short, succinct and accurate disclaimers" to accompany the Pearson plaintiffs' proposed dietary supplement health claim for folic acid/neural tube defects, a Washington, D.C. judge ruled Feb. 1 in a firmly worded opinion.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet